From: New insights on CRISPR/Cas9-based therapy for breast Cancer
Cancer type | Mouse strain | Vector | Target gene(s) | Reference |
---|---|---|---|---|
Lung adenocarcinoma | Kraslsl-G12D/+ | Lentivirus | NKX, PTEN, APC | [41] |
Lung adenocarcinoma | CD1 | Adenovirus | EML4 | [42] |
Burkitt lymphoma | Arf/− EμMyc | Retrovirus | p53 | [43] |
Glioblastoma | Crl:CD1 mice | Transfection | TRP53, PTEN, NF1 | [10] |
Acute myeloid leukemia | C57Bl/6 mice | Lentivirus | DNMT3A, EZH2, RUNX1 | [1] |
Burkitt lymphoma | Eμ--Myc mice | Lentivirus | p53 | [44] |
Pancreatic adenocarcinoma | KrasLSL-G12D/+ | Lentivirus | LKB1 | [45] |
Lung metastases | KrasG12D/+; p53−/− | Lentiviral | Multiple hits | [46] |
Tumor regression | Foxn1numice | Transfection | PKCβ A509T | [47] |